Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA: 600329)

Tianjin Pharmaceutical Da Ren Tang Group Corporation Statistics

Total Valuation

Tianjin Pharmaceutical Da Ren Tang Group Corporation has a market cap or net worth of CNY 22.41 billion. The enterprise value is 22.23 billion.

Market Cap	22.41B
Enterprise Value	22.23B

Important Dates

The last earnings date was Thursday, October 31, 2024.

Earnings Date	Oct 31, 2024
Ex-Dividend Date	Jul 12, 2024

Share Statistics

Tianjin Pharmaceutical Da Ren Tang Group Corporation has 770.16 million shares outstanding. The number of shares has decreased by -0.51% in one year.

Current Share Class	n/a
Shares Outstanding	770.16M
Shares Change (YoY)	-0.51%
Shares Change (QoQ)	-0.33%
Owned by Insiders (%)	2.70%
Owned by Institutions (%)	6.03%
Float	418.21M

Valuation Ratios

The trailing PE ratio is 27.78 and the forward PE ratio is 22.79.

PE Ratio	27.78
Forward PE	22.79
PS Ratio	3.22
PB Ratio	4.03
P/TBV Ratio	n/a
P/FCF Ratio	24.94
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.97, with an EV/FCF ratio of 21.42.

EV / Earnings	23.84
EV / Sales	2.76
EV / EBITDA	23.97
EV / EBIT	27.90
EV / FCF	21.42

Financial Position

The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.20.

Current Ratio	1.70
Quick Ratio	1.05
Debt / Equity	0.20
Debt / EBITDA	1.38
Debt / FCF	1.24
Interest Coverage	21.16

Financial Efficiency

Return on equity (ROE) is 14.18% and return on invested capital (ROIC) is 6.63%.

Return on Equity (ROE)	14.18%
Return on Assets (ROA)	4.69%
Return on Capital (ROIC)	6.63%
Revenue Per Employee	1.74M
Profits Per Employee	201,856
Employee Count	4,619
Asset Turnover	0.76
Inventory Turnover	2.60

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.21% in the last 52 weeks. The beta is 0.76, so Tianjin Pharmaceutical Da Ren Tang Group Corporation's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	-0.21%
50-Day Moving Average	32.39
200-Day Moving Average	32.02
Relative Strength Index (RSI)	48.04
Average Volume (20 Days)	6,258,117

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Tianjin Pharmaceutical Da Ren Tang Group Corporation had revenue of CNY 8.04 billion and earned 932.37 million in profits. Earnings per share was 1.21.

Revenue	8.04B
Gross Profit	3.74B
Operating Income	796.76M
Pretax Income	1.06B
Net Income	932.37M
EBITDA	923.83M
EBIT	796.76M
Earnings Per Share (EPS)	1.21

Balance Sheet

The company has 1.50 billion in cash and 1.28 billion in debt, giving a net cash position of 214.58 million or 0.28 per share.

Cash & Cash Equivalents	1.50B
Total Debt	1.28B
Net Cash	214.58M
Net Cash Per Share	0.28
Equity (Book Value)	6.45B
Book Value Per Share	8.34
Working Capital	2.93B

Cash Flow

In the last 12 months, operating cash flow was 1.17 billion and capital expenditures -137.06 million, giving a free cash flow of 1.04 billion.

Operating Cash Flow	1.17B
Capital Expenditures	-137.06M
Free Cash Flow	1.04B
FCF Per Share	1.35

Margins

Gross margin is 46.50%, with operating and profit margins of 9.91% and 11.60%.

Gross Margin	46.50%
Operating Margin	9.91%
Pretax Margin	13.15%
Profit Margin	11.60%
EBITDA Margin	11.49%
EBIT Margin	9.91%
FCF Margin	12.91%

Dividends & Yields

This stock pays an annual dividend of 1.28, which amounts to a dividend yield of 3.78%.

Dividend Per Share	1.28
Dividend Yield	3.78%
Dividend Growth (YoY)	14.29%
Years of Dividend Growth	2
Payout Ratio	106.14%
Buyback Yield	0.51%
Shareholder Yield	4.28%
Earnings Yield	3.60%
FCF Yield	4.01%

Stock Splits

The last stock split was on July 5, 2010. It was a forward split with a ratio of 2.

Last Split Date	Jul 5, 2010
Split Type	Forward
Split Ratio	2

Scores

Tianjin Pharmaceutical Da Ren Tang Group Corporation has an Altman Z-Score of 4.7.

Altman Z-Score	4.7
Piotroski F-Score	n/a